Results 21 to 30 of about 63,132 (220)
Molecular Therapy: Oncolytics, 2023 Tumor-specific overexpression of receptors enables a variety of targeted cancer therapies, exemplified by peptide-receptor radiotherapy (PRRT) for somatostatin receptor (SSTR)-positive neuroendocrine tumors.
Kathryn Ottolino-Perry +9 more
doaj +1 more source
Clinical Infectious Diseases, 2003 The resumption of smallpox vaccination for health care workers and other first responders has raised concern about the occurrence of complications in people with immunodeficiency disorders, including those infected with human immunodeficiency virus.
Mike, Bray, Mary E, Wright
openaire +2 more sources
Dairy production practices and associated risks for bovine vaccinia exposure in cattle, Brazil
New Microbes and New Infections, 2017 A cross-sectional serosurvey was performed to identify environmental features or practices of dairy farms associated with risk for exposure to vaccinia-like viruses in dairy cattle in Brazil.
I.A. Borges +10 more
doaj +1 more source
Viruses, 2023 The ongoing global Monkeypox outbreak that started in the spring of 2022 has reinforced the importance of protecting the population using live virus vaccines based on the vaccinia virus (VACV).
Ryan S. Noyce +10 more
doaj +1 more source
Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants? [PDF]
, 2010 Background: Vaccinia virus strain Lister Elstree (VACV) is a test virus in the DVV/RKI guidelines as representative of the stable enveloped viruses.
Jochen Steinmann +8 more
core +2 more sources
Vaccinia virus replication is not affected by APOBEC3 family members [PDF]
, 2006 Background: The APOBEC3G protein represents a novel innate defense mechanism against retroviral infection. It facilitates the deamination of the cytosine residues in the single stranded cDNA intermediate during early steps of retroviral infection.
Sutter Gerd +17 more
core +1 more source
Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults
Emerging Infectious Diseases, 2023 Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71–80 years of age.
Iván Sanz-Muñoz +9 more
doaj +1 more source
Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?
Viruses, 2015 The last few years have seen an increased interest in immunotherapy in the treatment of malignant disease. In particular, there has been significant enthusiasm for oncolytic virotherapy, with a large amount of pre-clinical data showing promise in animal ...
Samantha Turnbull +5 more
doaj +1 more source
The Rise and Fall of Modern Plagues
Molecular Frontiers Journal, 2020 Millennia separate smallpox, the oldest pandemic, and COVID-19, the newest. Both calamities arose from an opportunistic virus amid human crowding. A vaccine for smallpox existed since the late 18th century, but it took worldwide public health strategy to
G. Terry Sharrer
doaj +1 more source
A new inhibitor of apoptosis from vaccinia virus and eukaryotes. [PDF]
, 2007 A new apoptosis inhibitor is described from vaccinia virus, camelpox virus, and eukaryotic cells. The inhibitor is a hydrophobic, multiple transmembrane protein that is resident in the Golgi and is named GAAP (Golgi anti-apoptotic protein).
Hollinshead, M +19 more
core +1 more source